Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Smith

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular and Cellular Endocrinology|September 23, 2015
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsKatja Kiseljak-Vassiliades, Mei Xu, Taylor S Mills, et al.
The Prostate|October 21, 2014
Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostateJames R Lambert, Ramon J Whitson, Kenneth A Iczkowski, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular and Cellular Endocrinology|September 23, 2015
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsKatja Kiseljak-Vassiliades, Mei Xu, Taylor S Mills, et al.
The Prostate|October 21, 2014
Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostateJames R Lambert, Ramon J Whitson, Kenneth A Iczkowski, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 2